High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
IonQ (IONQ) shares rose 9.5% on Thursday, closing at $40.34 after six sessions that had mostly gone the other way. The reason on offer was research: quantum algorithms running inside mainstream engineering software, developed with Synopsys, sped up complex industrial design by up to 14.6%. That is genuine progress. It is also not a sale, and the price you pay for IonQ already assumes a great many sales.
Synopsys (SNPS) sells the design software and the interface IP that chip makers need to get AI silicon built, and its stock has still gone backwards over the past year. At about $370 the shares sit at their 52-week low. Reported margins have fallen sharply over the past year. Free cash flow tells a different story, and the gap between cash and reported profit is the case worth arguing here.
Key Stats for Synopsys Stock 52-Week Range: $362. 55 to $539.
SNPS stands out over CEVA as AI-driven EDA growth, recurring revenues, strong cash flow and better price performance strengthen its investment case.
Wells Fargo raises price target on Synopsys stock to $475. Here’s what made analyst Joe Quatrochi upgrade SNPS shares today.
Morgan Stanley upgrades Synopsys stock to "Overweight." Here’s why analyst Lee Simpson sees significant upside in SNPS shares from current levels.
The chip design giant is pushing into a new, more lucrative business model, and while its stock has a strong record of bouncing back, there's a catch you can't ignore.
Investing.com -- Morgan Stanley has upgraded Synopsys to Overweight and turned more selective on European semiconductor stocks, citing widening valuation dispersion and signs that the memory cycle is nearing a late-cycle turn.
Wall Street returns from summer vacation to a market suddenly bracing for a rate hike, with fresh analyst calls on Intel, Lockheed Martin, Amgen, and SpaceX adding more pressure points to an already tense week.
Ceva has fallen nearly 19% in a month despite Q2 beats and solid growth, but its premium valuation suggests investors may want to wait before buying.
Opening Bid Host Brooke DiPalma is joined by the panel of Prime Capital Financial chief investment officer Will McGough, Slatestone Wealth chief market strategist Kenny Polcari, and F.L. Putnam Investment Management co-chief market strategist & portfolio manager Ellen Hazen to weigh whether now is the time to buy into software stocks.
Synopsys (SNPS) is back in focus after its third quarter fiscal 2026 report on 26 August, which showed stronger than expected revenue and earnings, as well as a raised full year outlook supported by AI driven demand. The Q3 surprise and higher guidance triggered a sharp short term rebound in Synopsys, with a 1 day share price return of 13.39% and a 30 day share price return of 21.12%. However, the total shareholder return over one year is still down 24.06%, so recent momentum is picking up...
The chip design software company reported $2.48 billion in quarterly revenue and lifted its full-year revenue target to $9.715 billion at the midpoint
Synopsys beats Q3 estimates as EDA and Ansys fuel strong growth, while higher margins and an upgraded fiscal 2026 outlook add momentum.
Investing.com -- Synopsys is positioned for a stronger fiscal 2027 as demand for electronic design automation and chip-design intellectual property improves, Baird said, upgrading the semiconductor software provider to Outperform and raising its price target to $560.
Synopsys delivered third-quarter results ahead of Wall Street expectations and raised its fiscal 2026 outlook, supported by broad-based business growth and increasing demand linked to artificial intelligence. Shares nevertheless slipped around 2% in premarket trading on Thursday as investors assessed the degree of upside in the latest forecasts.
Investing.com --Synopsys shares fell in extended trading on Wednesday despite the chip-design software maker delivering third-quarter results above Wall Street expectations and raising its full-year outlook, as investors appeared to focus on the limited upside in its latest forecasts.
Synopsys (SNPS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Investing.com -- Mizuho said the release of Moonshot's Kimi K3 model reinforces its agentic AI thesis for electronic design automation software rather than threatening it, recommending investors buy the dip in Synopsys and Cadence Design Systems following last week's selloff.
Synopsys makes the software every chipmaker needs, so it profits regardless of who wins the AI race. Yet its stock fell after a strong quarter, and the reason isn’t obvious from the numbers alone.
A critical chip design stock has fallen back to a floor it has defended six times before, forcing investors to decide if history is a guide or a trap.
Investing.com -- Benchmark initiated coverage of electronic design automation (EDA) software leaders Synopsys and Cadence Design Systems with Buy ratings, citing strong long-term demand driven by artificial intelligence, semiconductor design complexity and resilient industry fundamentals.
Cadence leads in 2nm partnerships while Synopsys scales broader capabilities, but their financial profiles and risk exposures diverge sharply.
Synopsys (NASDAQ:SNPS) has become one of the most important picks-and-shovels plays on the AI buildout, yet the stock has quietly slipped 16.43% over the past year. Our 24/7 Wall St. price target for Synopsys is $516.71, implying 18.2% upside from the current $437.16 level. Our recommendation is buy, at a 90% confidence level, one of ... Synopsys Could Still Be One of the Smartest AI Stocks to Buy in 2026
Synopsys, Inc. (NASDAQ:SNPS) is among the Best Semiconductor Stocks. On June 23, Piper Sandler upgraded Synopsys, Inc. (NASDAQ:SNPS) to “Overweight” from Neutral. The analyst raised the price target to $550 from $450 on the shares. Analyst Clarke Jeffries said the firm expects a faster-than-anticipated recovery in Synopsys’ intellectual property business. The analyst noted improving expectations for […]
Investing.com -- Piper Sandler upgraded semiconductor design software maker Synopsys to Overweight from Neutral and raised its price target to $550 from $450, citing improving prospects for the company's intellectual property (IP) business as Intel's foundry ambitions gain traction.
The average brokerage recommendation (ABR) for Synopsys (SNPS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Is CDNS a good stock to buy? We came across a bullish thesis on Cadence Design Systems, Inc. on ARMR Report Be The Smart Money’s Substack by Bret Rosenthal. In this article, we will summarize the bulls’ thesis on CDNS. Cadence Design Systems, Inc.’s share was trading at $394.24 as of June 8th. CDNS’s trailing and forward […]
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
